Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

about

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Item

http://www.wikidata.org/entity/Q50915503

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@en

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@nl

type

Item

label

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@en

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@nl

prefLabel

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@en

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@nl

P1476

Lipid-Lowering Therapy in HIV- ...... f Substance-Related Disorders.

@en

P2093

Amneris E Luque

http://www.w3.org/2001/XMLSchema#string

Barbara M Gripshover

http://www.w3.org/2001/XMLSchema#string

Barry S Zingman

http://www.w3.org/2001/XMLSchema#string

Charles S Venuto

http://www.w3.org/2001/XMLSchema#string

Cindy Bednasz

http://www.w3.org/2001/XMLSchema#string

Gene D Morse

http://www.w3.org/2001/XMLSchema#string

Jie Gu

http://www.w3.org/2001/XMLSchema#string

Margaret A Fischl

http://www.w3.org/2001/XMLSchema#string

Qing Ma

http://www.w3.org/2001/XMLSchema#string

Robin DiFrancesco

http://www.w3.org/2001/XMLSchema#string

P2860

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary.

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial.

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavir.

Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.

P304

280-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570161114666160106151652

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26733388

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4879810

http://www.w3.org/2001/XMLSchema#string